Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 10.
doi: 10.14309/ajg.0000000000003644. Online ahead of print.

Local Postprocedural Cryoprevention Significantly Reduces the Incidence of Post-ERCP Pancreatitis: A Multicenter Randomized Controlled Trial

Shunjiro Azuma  1 , Yosuke Kobayashi  2 , Ryo Harada  3 , Kei Yane  4 , Kenji Sawada  5 , Akiko Tsujimoto  5 , Osamu Inatomi  6 , Tomoaki Matsumori  7 , Kenichi Yoshimura  8 , Shujiro Yazumi  1 , Akira Kurita  9   10
Affiliations

Local Postprocedural Cryoprevention Significantly Reduces the Incidence of Post-ERCP Pancreatitis: A Multicenter Randomized Controlled Trial

Shunjiro Azuma et al. Am J Gastroenterol. .

Abstract

Introduction: Postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is a common, potentially serious adverse event of ERCP. Although rectal nonsteroidal anti-inflammatory drugs are recommended for prevention, their use in Japan is limited due to dosage concerns. This multicenter randomized controlled trial evaluated the efficacy and safety of ice water irrigation to the papilla in reducing PEP.

Methods: This single-blind trial enrolled 880 adults with a native papilla undergoing ERCP at 8 hospitals in Japan (March 2022-February 2024). After 3 withdrawals, 877 were analyzed (cryoprevention: 434; control: 443). The primary outcome was PEP incidence, defined as abdominal pain within 24 hours and serum amylase or lipase ≥3 times the upper normal limit. Secondary outcomes included cholangitis, bleeding, perforation, and mortality.

Results: PEP incidence was significantly lower in the cryoprevention group (3.2%; 95% CI, 1.7%-5.4%) than the control group (6.8%; 95% CI, 4.6%-9.6%) ( P = 0.02), with absolute and relative risk reductions of 3.6% and 52.4%. No significant differences were observed in secondary outcomes, including cholangitis (0.9% vs 1.1%; P = 1.00), bleeding (1.4% vs 2.5%; P = 0.33), or perforation (0.9% vs 0.2%; P = 0.21). One control patient died from severe PEP. No adverse events related to cryoprevention were reported.

Discussion: Cryoprevention using ice water significantly reduced PEP incidence, demonstrating a safe, effective, and low-cost strategy. This approach offers a practical alternative, where nonsteroidal anti-inflammatory drugs use is limited.

Keywords: PEP; cryoprevention; ice water; post-ERCP pancreatitis.

PubMed Disclaimer

References

    1. Kochar B, Akshintala VS, Afghani E, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: A systematic review by using randomized, controlled trials. Gastrointest Endosc 2015;81(1):143–9.e9.
    1. Testoni PA, Mariani A, Giussani A, et al. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: A prospective multicenter study. Am J Gastroenterol 2010;105(8):1753–61.
    1. Tomoda T, Kato H, Ueki T, et al. Combination of diclofenac and sublingual nitrates is superior to diclofenac alone in preventing pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2019;156(6):1753–60.e1.
    1. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012;366(15):1414–22.
    1. Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020;52(2):127–49.

LinkOut - more resources